VANGUARD Consortium Meeting 2024 in Innsbruck, Austria
On January 27-28, the VANGUARD general assembly took place in Innsbruck, Austria. Nineteen participants representing the consortium’s nine project partners gathered for a two-day program consisting of project updates, planning […]
Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas
A new publication on Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas in Law, Technology and Humans. Abstract Regenerative […]
Review article on Clinical Translation of Bio-Artificial Pancreas Therapies
As part of the Transplant International special issue on The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering, VANGUARD partners published a review article […]
VANGUARD Project Leaps Forward: Successful Bi-Annual Meeting in Milan
On the 3rd and 4th of July, the cosmopolitan city of Milan, Italy, played host to the bi-annual project meeting of VANGUARD. The meeting was organised by Lorenzo Piemonti and […]
Annual VANGUARD meeting held in Igls, Austria
Team members of the VANGUARD project travelled to Igls in Austria for the annual consortium meeting which was held on 22 January 2023. The full day meeting covered the research […]
VANGUARD publication on Advances and challenges of endocrine pancreas bioengineering available online
A new VANGUARD article has recently been published in Current Opinion in Endocrine and Metabolic Research. “Advances and challenges of endocrine pancreas bioengineering” – Islet transplantation is a valid treatment […]
VANGUARD Ethics Workshop
Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near […]
Research article: Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
A new VANGUARD research article on Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device has been published in Molecular Therapy, Methods & Clinical […]
